论文部分内容阅读
目的:对应用多巴酚丁胺与小剂量多巴胺对重症肺炎患儿进行辅助治疗的临床效果进行分析探究。方法:选取在我院接受治疗的100例重症肺炎患儿,将其平均分为试验组和对照组,对照组患儿采用常规治疗方法进行治疗,试验组患儿采用常规治疗结合小剂量多巴胺与多巴酚丁胺辅助治疗,对比分析两组患儿的临床治疗效果及主要体征改善时间情况。结果:分别对两组患儿进行治疗后,试验组患儿的总有效率(94.00%)明显高于对照组患儿的总有效率(64.00%),统计学上有意义(P<0.05)。试验组患儿的发热改善时间(3.1±1.1)d、心率恢复时间(1.2±0.4)d以及呼吸恢复时间(2.5±1.4)d明显低于对照组患儿发热改善时间(6.8±2.3)d、心率恢复时间(2.6±0.9)d以及呼吸恢复时间(4.5±1.3)d,统计学上有意义(P<0.05)。结论:应用多巴酚丁胺与小剂量多巴胺对重症肺炎患儿进行辅助治疗的临床效果显著,有效改善了患儿的临床症状,安全可靠,可以在广泛应用。
Objective: To analyze the clinical effects of dobutamine and low-dose dopamine in the adjuvant treatment of children with severe pneumonia. Methods: 100 children with severe pneumonia who were treated in our hospital were selected and divided equally into experimental group and control group. Children in control group were treated by routine treatment. The children in experimental group were treated with low-dose dopamine Dobutamine adjuvant therapy, comparative analysis of two groups of children with clinical treatment and the main signs of improvement time. Results: After treating the two groups of children respectively, the total effective rate (94.00%) in the experimental group was significantly higher than that in the control group (64.00%), which was statistically significant (P0.05) . The fever improvement time (3.1 ± 1.1) days, heart rate recovery time (1.2 ± 0.4) days and respiration recovery time (2.5 ± 1.4) days in the experimental group were significantly lower than those in the control group (6.8 ± 2.3 days) , Heart rate recovery time (2.6 ± 0.9) d and respiration recovery time (4.5 ± 1.3) d were statistically significant (P <0.05). Conclusion: The clinical effects of dobutamine and low-dose dopamine in adjuvant treatment of children with severe pneumonia are significant, and the clinical symptoms of children with severe pneumonia are effectively improved, which is safe and reliable and can be widely used.